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A NOVEL NR2E3 GENE MUTATION IN AUTOSOMAL RECESSIVE 




NR2E3 is a gene that encodes for photoreceptor cell specific nuclear 
receptor, which is involved in cone proliferation. The splice site mutation 
119-2A>C in NR2E3 (15q23) has been previously reported to underlie 
recessive enhanced cone S sensitivity syndrome, clumped pigmentary 
retinal degeneration, Goldman-Favre syndrome and also autosomal 
dominant and autosomal recessive retinitis pigmentosa (RP). However, 
the mutation c 571 + 2 T > C in NR2E3 has not been previously reported 
with retinal disease. We report a 44-year-old male patient who presented 
with night blindness since birth and acute onset decreased vision, with the 
compound heterozygous mutation c.119-2A>C and c.571+2T>C in the 
NR2E3 gene. A diagnosis of retinitis pigmentosa with cystic 
maculopathy was made and the patient was treated with oral carbonic 
anhydrase inhibitors, which lead to the partial resolution of foveal cysts 
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INTRODUCTION   
NR2E3 is a gene that encodes for photoreceptor cell specific nuclear 
receptor, which is involved in cone proliferation (Kobayashi M et al. 
1999). It targets rhodopsin and several other opsins, which are important 
for sight (Milam AH et al. 2002). It is predicted to affect normal protein 
splicing. NR2E3 mutations lead to macular schisis, with an increase in 
functional S cone-like cells, thickening of retinal layers, loss of retinal 
lamination, S and L cone function.  
 
CASE  
A 44 year-old man presented to the eye clinic with the chief complaint of 
decreased vision in the right eye for the past 6 months and non-
progressive lifelong difficulty of seeing in the dark. His visual acuity was 
6/6 in the right eye and hand movement close to face in the left eye. 
Fundus examination of the right eye revealed a slightly pale tilted optic 
disc, retinal pigmentary changes in the mid periphery, thin vessels, partial 
vitreous detachment and cystic changes in the macula (Fig 1.a). Left eye 
fundus examination revealed vitreous haze, a pigmented macular scar 
with and long-standing inferior retinal detachment (Fig 1.a). Pattern ERG 
and oscillatory potentials in the right eye were absent, with reduced flash 
and flicker amplitude and increased implicit time. Significant reduced 
30Hz flicker points to cone loss were present. Flash VEP revealed 
decreased flicker amplitude and increased implicit throughout the retina 
time. Full field pattern reversal VEP of the right eye revealed N75 -79 
milliseconds and P100 -117 milliseconds. Electro-oculogram revealed an 
arden index 118% in the right eye and 145 % in the left eye. Fundus 
fluorescein angiography revealed angiographic evidence of leakage from 
perifoveal capillaries in both the eyes (Fig 1.a). OCT revealed mild 
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thickening in the right eye with a cystic lesion in the right macula (Fig 
1.b). A possible diagnosis of retinoschisis was made and he was screened 
for mutation in the RSI gene, which turned out to be negative. His visual 
acuity in the right eye dropped to 6/36. He was prescribed Diamox 
(500mg po bd). His vision improved to 6/9 with the resolution of cysts 
after treatment with Diamox for 11 months. 6 months after discontinuing 
Diamox tablets, cystic spaces in the right macula increased again but the 
vision was stable and the patient was not keen to take Diamox because of 
its side effects (Fig 1.b). His present vision in the right eye is 6/9 and 
perception of light in the left eye. OCT shows minimal residual cysts in 
the right eye (Fig 1.b).  
 
The results of the retinal panel that was screened for 176 genes associated 
with retinal dystrophies by next generation sequencing revealed the 
heterozygous NR2E3 changes,(c.119-2A>C and c.571+2T>C) (OMIM 
*604485). There was no family history of inherited retinal dystrophy. 
Mother’s DNA had the same mutation but it was heterozygous, 
suggesting that she was a carrier. The mutation was in the trans form. The 
father’s DNA could not be tested, as he is no longer living. A diagnosis 
of autosomal recessive retinitis pigmentosa with cystic maculopathy, 




Fifty mutations in NR2E3 have been reported so far. The splice site 
mutation 119-2A>C in NR2E3 (15q23) has been previously reported to 
underlie recessive enhanced cone S sensitivity syndrome, clumped 
pigmentary retinal degeneration, Goldman-Favre syndrome and also 
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autosomal dominant and autosomal recessive retinitis pigmentosa (RP). 
0.25% cases of ARRP in Caucasians are ascribed to NR2E3 gene 
mutations. However, the mutation c 571 + 2 T > C in NR2E3 has not 
been previously reported with retinal disease. The prevalence of cystoid 
macular edema is about 10% to 15% in RP (Adackapara CA et al. 2008) 
and carbonic anhydrase inhibitors enhance sub retinal fluid absorption in 
macular edema. Their usefulness was proven in the treatment of macular 
cystoid changes (Nagelhus EA et al. 2005 & Ikeda Y et al. 2012). With 
the advent of clinical trials for inherited retinal dystrophies, it is 
important to identify the genes in retinal dystrophies to facilitate the 
development of new therapeutic interventions.  
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Fig 1.a: Fundus (A,B)and fundus fluorescein images (C-J)of the right and left eye  
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Fig 1.b: OCT showing the progression of cystic changes at the macula  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
